Tech Company Financing Transactions

Bioxodes Funding Round

Bioxodes secured a $13.1 million Series A funding round on 11/21/2023. Backers included private investors.

Transaction Overview

Company Name
Announced On
11/21/2023
Transaction Type
Venture Equity
Amount
$13,139,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to continue clinical development of drug candidate for patients with intracerebral hemorrhage.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Parc d'activités Aéropole Rue Santos-Dumont, 1
Gosselies, 6041
BE
Phone
Undisclosed
Email Address
Overview
Founded by an experienced group of seasoned healthcare and biotech executives with extensive experience in research, drug development, and commercialisation, Bioxodes is developing a portfolio of high value products derived from natural sources based on research conducted by Prof. Edmond Godfroid. The research was conducted in collaboration withacademic groups from Université Catholique de Louvain, Facultés Universitaires Notre Dame de la Paix Namur, and Université de Liège as well as with the Université de Neuchâtel, Switzerland.
Profile
Bioxodes LinkedIn Company Profile
Social Media
Bioxodes Company Twitter Account
Company News
Bioxodes News
Facebook
Bioxodes on Facebook
YouTube
Bioxodes on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Marc Dechamps
  Marc Dechamps LinkedIn Profile  Marc Dechamps Twitter Account  Marc Dechamps News  Marc Dechamps on Facebook
Chief Operating Officer
Edmond Godfroid
  Edmond Godfroid LinkedIn Profile  Edmond Godfroid Twitter Account  Edmond Godfroid News  Edmond Godfroid on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/21/2023: Supira Medical venture capital transaction
Next: 11/21/2023: Expanso venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary